Antibodies to receptor activator of nuclear factor-κ B ligand (RANKL)

Evangelos Terpos University of Athens School of Medicine, ‘Alexandra’ General Hospital, Department of Clinical Therapeutics, 5 Marathonomahon street, 14572, Drossia, Athens, Greece +30 210 7463803; +30 210 7464648; [email protected]

Dimitrios Christoulas University of Athens School of Medicine, ‘Alexandra’ General Hospital, Department of Clinical Therapeutics, 5 Marathonomahon street, 14572, Drossia, Athens, Greece +30 210 7463803; +30 210 7464648; [email protected]

Meletios-Athanassios Dimopoulos University of Athens School of Medicine, ‘Alexandra’ General Hospital, Department of Clinical Therapeutics, 5 Marathonomahon street, 14572, Drossia, Athens, Greece +30 210 7463803; +30 210 7464648; [email protected]

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Athanasios D Anastasilakis, Konstantinos A Toulis, Stergios A Polyzos & Evangelos Terpos. (2009) RANKL inhibition for the management of patients with benign metabolic bone disorders. Expert Opinion on Investigational Drugs 18:8, pages 1085-1102.
Read now

Evangelos Terpos, Eleni Efstathiou, Dimitrios Christoulas, Maria Roussou, Eirini Katodritou & Meletios-Athanassios Dimopoulos. (2009) RANKL inhibition: Clinical implications for the management of patients with multiple myeloma and solid tumors with bone metastases. Expert Opinion on Biological Therapy 9:4, pages 465-479.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Antibodies to receptor activator of nuclear factor-κ B ligand (RANKL)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Antibodies to receptor activator of nuclear factor-κ B ligand (RANKL)

Citations (2)

Read on this site (2)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date